서타라(CERT)는 NASDAQ에 상장된 Healthcare · Health Information Services 기업입니다. 현재가 $8.29 (-3.38%), 시가총액 $0.71B, 52주 최저~최고 $4.48 ~ $13.60.
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intell
서타라의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
서타라의 현재 주가는 $8.29 (-3.38%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
서타라의 시가총액은 약 $0.71B입니다.
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions,